Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

[A very elderly case of complete remission by chemotherapy in a patient of primary esophageal non-Hodgkin lymphoma].

Yamashita H, Asazuma N, Nakamura H, Igarashi H, Machinami R, Ogata I.

Nihon Shokakibyo Gakkai Zasshi. 2012 Mar;109(3):400-7. Japanese.

PMID:
22398905
2.
3.

Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan.

Tanaka T, Shimada K, Yamamoto K, Hirooka Y, Niwa Y, Sugiura I, Kitamura K, Kosugi H, Kinoshita T, Goto H, Nakamura S.

Ann Hematol. 2012 Mar;91(3):383-90. doi: 10.1007/s00277-011-1306-0. Epub 2011 Aug 6.

PMID:
21822617
4.
5.

Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma.

Shimada K, Kosugi H, Narimatsu H, Shimada S, Suzuki T, Ito M, Kinoshita T, Mori N, Naoe T.

J Clin Exp Hematop. 2008 Apr;48(1):25-8.

6.

Treatment of a patient with adnexal lymphoma with Rituximab.

Bilgir O, Bilgir F, Calan M, Yuksel A, Sari F, Oztekin O.

Transfus Apher Sci. 2011 Apr;44(2):135-7. doi: 10.1016/j.transci.2011.01.002. Epub 2011 Feb 12.

PMID:
21320802
7.

Aggressive lymphoma: improving treatment outcome with rituximab.

Coiffier B, Pfreundschuh M, Stahel R, Vose J, Zinzani PL.

Anticancer Drugs. 2002 Nov;13 Suppl 2:S43-50.

PMID:
12710590
8.

The therapeutic use of rituximab in non-Hodgkin's lymphoma.

Marcus R, Hagenbeek A.

Eur J Haematol Suppl. 2007 Jan;(67):5-14. Review.

PMID:
17206982
9.

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.

Peters FP, Fickers MM, Erdkamp FL, Wals J, Wils JA, Schouten HC.

Ann Hematol. 2001 Jul;80(7):406-10.

PMID:
11529466
10.

[Clinical trial of the monoclonal antibody drug mabthera (Rituximab) in the treatment of non-Hodgkin lymphoma].

Korolenko VO, Gershanovich ML, Leenman EE, Tikhonova VV.

Vopr Onkol. 2003;49(4):459-63. Russian.

PMID:
14569937
11.

Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi.

Merli F, Luminari S, Rossi G, Mammi C, Marcheselli L, Tucci A, Ilariucci F, Chiappella A, Musso M, Di Rocco A, Stelitano C, Alvarez I, Baldini L, Mazza P, Salvi F, Arcari A, Fragasso A, Gobbi PG, Liberati AM, Federico M.

Leuk Lymphoma. 2012 Apr;53(4):581-8. doi: 10.3109/10428194.2011.621565. Epub 2011 Nov 15.

PMID:
21895543
12.

Primary non-Hodgkin's lymphoma of the esophagus.

Mengoli M, Marchi M, Rota E, Bertolotti M, Gollini C, Signorelli S.

Am J Gastroenterol. 1990 Jun;85(6):737-41.

PMID:
2353695
13.

Community-based trial of R-CHOP and maintenance rituximab for intermediate- or high-grade non-Hodgkin lymphoma with first-cycle filgrastim for older patients.

Case DC Jr, Desch CE, Kalman LA, Vongkovit P, Mena RR, Fridman M, Allen B.

Clin Lymphoma Myeloma. 2007 Mar;7(5):354-60.

PMID:
17562245
14.

[A case of retroperitoneal malignant lymphoma successfully treated by chemotherapy].

Nakao A, Kamada K, Imamura M, Sakagami K, Uda M, Mitsuoka S, Ito H.

Gan To Kagaku Ryoho. 1998 Aug;25(10):1599-602. Review. Japanese.

PMID:
9725055
15.

Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report.

Szánthó A, Bálega J Já, Csapó Z, Sréter L Lí, Matolcsy A, Papp Z.

Gynecol Oncol. 2003 Apr;89(1):171-4.

PMID:
12694673
16.

Malignant lymphoma of the vagina successfully treated with rituximab, adryamicin, cyclophosphamide, vincristine sulfate, and prednisolone.

Nasu K, Okamoto M, Nishida M, Takai N, Narahara H.

Eur J Gynaecol Oncol. 2012;33(2):219-22.

PMID:
22611969
17.

Rituximab provides durable remission in a patient with refractory aggressive diffuse B-cell lymphoma failing salvage chemotherapy.

Robach E, Ustun C, Kallab A, Burgess RE, Jillella AP.

Leuk Lymphoma. 2002 Nov;43(11):2235-6.

PMID:
12533055
18.
19.

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.

Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST.

Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.

PMID:
21520001
20.

Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma.

Tulpule A, Espina BM, Berman N, Buchanan LH, Smith DL, Sherrod A, Dharmapala D, Gee C, Boswell WD, Nathwani BN, Welles L, Levine AM.

Clin Lymphoma Myeloma. 2006 Jul;7(1):59-64.

PMID:
16879771

Supplemental Content

Support Center